Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability
Launched by UNIVERSITY HOSPITAL, BREST · Jun 29, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how individuals with certain psychological challenges, like childhood borderline psychosis and other psychotic disorders, recognize themselves and distinguish themselves from others. The researchers want to see if there are differences in these abilities between young people who are struggling with these issues and healthy individuals. The goal is to better understand how these psychological vulnerabilities affect self-perception.
To participate, you need to be between 15 and 25 years old and meet specific criteria related to your mental health. For example, patients must be assessed as being at "Ultra High Risk" for certain psychological conditions. Healthy volunteers must not know the patients they are matched with. Everyone must agree to participate, and parents must sign for those under 18. Participants can expect to take part in activities that assess their self-recognition abilities. It's important to note that those with a history of epilepsy or migraines, claustrophobia, or certain vision problems cannot join the study.
Gender
ALL
Eligibility criteria
- Inclusion criteria for patients:
- • Aged from 15 to 25 years
- • Subject meeting the Ultra High Risk criteria at CAARMS and / or SPI-A
- • Signature of the consent (participants and parents for minors)
- • Subject affiliated to the social security scheme or benefiting from such a scheme
- Inclusion criteria for healthy volunteers:
- • Aged from 15 to 25 years
- • Subject not familiar to the patient to whom it is matched
- • Signature of the consent (participants and parents for minors)
- • Subject affiliated to the social security scheme or benefiting from such a scheme
- Exclusion Criteria for both patients and healthy volunteers:
- • History of epilepsy and / or migraine (due to the epileptogenic potential of light stimuli)
- • Refusal of participation of the minor even if the legal representatives want the subject to participate in the study
- • Claustrophobia
- • Wearing glasses
- • Abnormal right and left visual acuity without contact lenses
- • Distinctive signs on the face which cannot be temporarily removed
- • Subject under legal protection (curators / guardianship) or deprived of liberty
About University Hospital, Brest
The University Hospital of Brest is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. With a strong emphasis on interdisciplinary collaboration, the hospital serves as a hub for cutting-edge clinical trials aimed at improving treatment outcomes across various medical specialties. Leveraging its robust academic affiliations and state-of-the-art facilities, the University Hospital of Brest is committed to fostering scientific discovery and enhancing the quality of life for patients through evidence-based practices and pioneering research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bohars, , France
Patients applied
Trial Officials
Nathalie LAVENNE
Principal Investigator
CHRU BREST
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials